Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice

Braekow Pauline, Neumann Joachim, Kirchhefer Uwe, Gergs Ulrich

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (44)

  1. Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes. 2025-06-15 · Expand citations
  2. Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review. 2025-06-01 · Expand citations
  3. Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges. 2025-05-01 · Expand citations
  4. Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives. 2025-04-01 · Expand citations
  5. Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans 2024-07-01 · Expand citations
  6. Effects of hallucinogenic drugs on the human heart. 2024-01-01 · Expand citations
  7. Psilocybin and Other Classic Psychedelics in Depression. 2024-01-01 · Expand citations
  8. Cardiovascular safety of psychedelic medicine: current status and future directions. 2023-12-01 · Expand citations
  9. Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. 2023-08-01 · Expand citations
  10. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. 2023-01-01 · Expand citations
  11. Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. 2022-04-19 · Expand citations
  12. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. 2022-01-01 · Expand citations
  13. The Therapeutic Potential of Psilocybin. 2021-05-15 · Expand citations
  14. Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin 2021-01-01 · Expand citations
  15. Psilocybin: from ancient magic to modern medicine. 2020-10-01 · Expand citations
  16. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  17. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man 1997-06-01 · Expand citations
  18. 10.1007/164_2016_15
  19. 10.1007/bf00165383
  20. 10.1007/bf00167185
  21. 10.1007/bf00167212
  22. 10.1007/bf00176614
  23. 10.1007/bf01812150
  24. 10.1007/bf01852128
  25. 10.1007/s00210-004-0963-0
  26. 10.1007/s00210-023-02573-8
  27. 10.1007/s00210-023-02591-6
  28. 10.1016/0014-2999(94)90507-x
  29. 10.1016/0024-3205(80)90209-x
  30. 10.1016/b978-0-12-823356-6.00002-0
  31. 10.1016/j.jjcc.2023.06.013
  32. 10.1016/j.pharmthera.2005.12.004
  33. 10.1016/s0026-895x(25)14916-x
  34. 10.1097/00005344-199001001-00004
  35. 10.1097/00005344-199309000-00019
  36. 10.1124/jpet.103.063065
  37. 10.1124/jpet.118.255711
  38. 10.1152/ajpcell.00318.2020
  39. 10.1152/ajpheart.00691.2009
  40. 10.1186/s12974-022-02508-9
  41. 10.1371/journal.pone.0045489
  42. 10.3389/fphar.2021.732842
  43. 10.3390/ijms24054749
  44. 10.3390/ijms24054765

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.